Israel Active

Among this summary of promising Israeli IBD breakthroughs is the work of Weizmann Institute scientists to enhance the resolution of ultrasound. They can now identify tiny tumors and lesions, enabling cancer and Crohn’s patients to begin early treatment.

Israeli non-profit IsraAID is bringing four children from Juba in South Sudan to Israel for surgery from surgeons at Save a Child’s Heart (SACH). Due to Covid, the children have been waiting for nearly 3 years in internally displaced people (IDP) camps.

Israel’s MASHAV (International development cooperation program) has been working to bring ten Ukrainian children and their families to Israel for cancer treatment. The video highlights some of the huge challenges involved.

Israel’s SocialMind Autism has released an AI-powered app program based on Pivotal Response Treatment (PRT). Its 22 lessons helps parents increase an autistic child’s motivation to learn, initiate communication, and improve their social skills.

UK-based national homecare franchise provider Caremark is using Israel’s Connecteam (see previously) to manage and engage more than 7,000 remote caregivers across some 115 UK franchise offices. Connecteam is used by 20,000 companies in 80 countries and many industries.

Israel’s ChroniSense Medical has developed the Polso FDA-approved medical sensor smartwatch. It accurately monitors vital signs, such as blood oxygen saturation, pulse rate, and respiration rate. It comes with a mobile app for patients, and a cloud-based platform for clinicians.

For the first time, Jerusalem’s Shaare Zedek Medical Center treated a 70-year-old Israeli patient suffering for 20 years from essential tremor, using Deep Brain Stimulation devices from US company Abbott and Israel’s Alpha Omega (see previously). It made a significant improvement.

Almost like the 1966 sci-fi movie Fantastic Voyage, Israel’s Bionaut Labs develops microscale robots for the treatment of brain diseases and disorders. Bionaut uses magnetic propulsion to navigate the human body and deliver medicine locally to avoid side effects and toxicity.

Israel’s Bar-Ilan Prof. Yanay Ofran has invented antibodies to attack tumors, using computers and then produced them from amino acids in a process akin to 3D printing. His startup Biolojic Design created Aulos Bioscience which is conducting human trials of AU-007 in Australia.

The Envue feeding tube placement system from Israel’s Envizion Medical (see previously) has been used tens of thousands of times in dozens of US hospitals including the Cleveland Clinic and the St. Vincent network of hospitals. It has been 100% successful and saved many lives.